In the past week, EDAP stock has gone down by -1.39%, with a monthly decline of -13.77% and a quarterly plunge of -25.78%. The volatility ratio for the week is 5.77%, and the volatility levels for the last 30 days are 7.28% for EDAP TMS S.A. ADR The simple moving average for the past 20 days is -6.51% for EDAP’s stock, with a -53.53% simple moving average for the past 200 days.
Is It Worth Investing in EDAP TMS S.A. ADR (NASDAQ: EDAP) Right Now?
Additionally, the 36-month beta value for EDAP is 0.35. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EDAP is 36.91M and currently, short sellers hold a 0.12% ratio of that float. The average trading volume of EDAP on December 27, 2024 was 159.49K shares.
EDAP) stock’s latest price update
EDAP TMS S.A. ADR (NASDAQ: EDAP)’s stock price has gone decline by -2.74 in comparison to its previous close of 2.19, however, the company has experienced a -1.39% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-12-04 that HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatments Positive study results are expected to drive further adoption of Focal One as a first line treatment option for the management of localized prostate cancer Study shows Focal One Robotic HIFU is non-inferior to surgery, meeting primary endpoint of non-inferiority for Salvage Treatment-free Survival (STFS) after High Intensity Focused Ultrasounds (HIFU) compared to Radical Prostatectomy (RP) at 30 months Study shows that patients receiving HIFU had better outcomes with respect to urinary continence and erectile function compared to patients receiving RP LYON, France, December 4, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the publication of the full results from the HIFI study in the prestigious, peer-reviewed journal, European Urology, which has the highest impact factor amongst scientific journals focused in urology. The study evaluated HIFU versus radical prostatectomy (RP) as a first line treatment of localized prostate cancer.
Analysts’ Opinion of EDAP
Many brokerage firms have already submitted their reports for EDAP stocks, with Jefferies repeating the rating for EDAP by listing it as a “Buy.” The predicted price for EDAP in the upcoming period, according to Jefferies is $11 based on the research report published on November 01, 2022 of the previous year 2022.
Piper Sandler, on the other hand, stated in their research note that they expect to see EDAP reach a price target of $13. The rating they have provided for EDAP stocks is “Overweight” according to the report published on April 28th, 2021.
B. Riley FBR gave a rating of “Buy” to EDAP, setting the target price at $5.50 in the report published on April 15th of the previous year.
EDAP Trading at -14.60% from the 50-Day Moving Average
After a stumble in the market that brought EDAP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.94% of loss for the given period.
Volatility was left at 7.28%, however, over the last 30 days, the volatility rate increased by 5.77%, as shares sank -10.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.55% lower at present.
During the last 5 trading sessions, EDAP fell by -1.39%, which changed the moving average for the period of 200-days by -71.37% in comparison to the 20-day moving average, which settled at $2.28. In addition, EDAP TMS S.A. ADR saw -59.66% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EDAP starting from LANCE WILLSEY, who proposed sale 30,000 shares at the price of $2.47 back on Nov 26 ’24. After this action, LANCE WILLSEY now owns shares of EDAP TMS S.A. ADR, valued at $74,160 using the latest closing price.
WILLSEY LANCE, the Director of EDAP TMS S.A. ADR, proposed sale 22,702 shares at $2.50 during a trade that took place back on Nov 25 ’24, which means that WILLSEY LANCE is holding shares at $56,743 based on the most recent closing price.
Stock Fundamentals for EDAP
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.41 for the gross margin
The net margin for EDAP TMS S.A. ADR stands at -0.35. The total capital return value is set at -0.41. Equity return is now at value -35.41, with -22.13 for asset returns.
Based on EDAP TMS S.A. ADR (EDAP), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -5.05. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -11150.6.
Currently, EBITDA for the company is -18.39 million with net debt to EBITDA at -0.32. When we switch over and look at the enterprise to sales, we see a ratio of 1.3. The receivables turnover for the company is 3.89for trailing twelve months and the total asset turnover is 0.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.45.
Conclusion
In conclusion, EDAP TMS S.A. ADR (EDAP) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
